Health/Biotech | Boston Citybizlist

Health/Biotech

Epizyme Prices Shares in the $13-15 Range
Posted on May 23, 2013
Acton Pharmaceuticals Raises $7 million
Posted on May 22, 2013
Ironwood Pharmaceuticals Proposes 10.5M Stock Offering
Posted on May 20, 2013
Cubist Achieves Top Biotech Ranking in Globe 100 List
Posted on May 19, 2013
Thermedical Secures $5.5 Million in Series A2 Financing Round
Posted on May 15, 2013
Celldex Therapeutics' Management Presents at Credit Suisse Antibody Day Conference (Transcript)
Posted on May 12, 2013
Lincoln Park Backs Publicly Traded Zalicus
Posted on May 8, 2013
NeuroPhage Pharmaceuticals Raises $6.4M
Posted on May 7, 2013
myonic GmbH Purchases Assets of Austrian Bearing Company APB
Posted on May 7, 2013
Preferred Acquires Acelleron Medical Products
Posted on May 7, 2013
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Posted on May 5, 2013
Idera Pharmaceuticals Prices $16.5M Offering
Posted on May 1, 2013
Nonotuck Resource Associates Continues Growth With Multiple New Hires
Posted on May 1, 2013
Biogen Idec - Too High Too Fast?
Posted on April 30, 2013
PAREXEL International Acquires HERON Group
Posted on April 30, 2013
New Haven Pharma Land $2M Loan From Horizon Tech Finance
Posted on April 26, 2013
Cancer Drug Developer Agenus Raises $5 Million
Posted on April 26, 2013
Q&A with Peter Cook, CEO of Cook & Company
Posted on April 25, 2013
Radius Health Completes $43 Million Financing
Posted on April 25, 2013
Vapotherm Closes $29M Financing
Posted on April 25, 2013

Pages